AT447016T
Test and model for alzheimer's disease
Abstract
[Subject] The model which can be used for screening of the substance which can treat Alzheimer's disease is offered. [Solution means] They are transformation hosts other than humans containing the 組換 polynucleotide which has the nucleic acid arrangement which encodes the allele of the quality (APP) of amyloid precursor protein of the mutation type humans relevant to the genetic genius of Alzheimer's disease. [Selection figure] Nothing
Term
Term ended
Expired 21 January 2012, 14.7 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
37 members in 11 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 9101307 | United Kingdom | A | |
| 9118445 | United Kingdom | A |
Members37
| Document | Office | Kind | |
|---|---|---|---|
| GB9101307D0 | United Kingdom | D0 | |
| GB9118445D0 | United Kingdom | D0 | |
| CA2101774A1 | Canada | A1 | |
| CA2372251A1 | Canada | A1 | |
| WO9213069A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU1169492A | Australia | A | |
| EP0568575A1 | European Patent Office (EPO) | A1 | |
| JPH06504441A | Japan | A | |
| AU652997B2 | Australia | B2 | |
| US5877015A | United States of America | A | |
| EP0971033A2 | European Patent Office (EPO) | A2 | |
| DE971033T1 | Germany | T1 | |
| US6300540B1 | United States of America | B1 | |
| JP2002306195A | Japan | A | |
| US2003165958A1 | United States of America | A1 | |
| EP0971033A3 | European Patent Office (EPO) | A3 | |
| JP3510244B2 | Japan | B2 | |
| JP2004261187A | Japan | A | |
| JP3574432B2 | Japan | B2 | |
| EP0568575B1 | European Patent Office (EPO) | B1 | |
| AT286971T | Austria | T | |
| ATE286971T1 | Austria | T1 | |
| DE69233468D1 | Germany | D1 | |
| DK0568575T3 | Denmark | T3 | |
| ES2236682T3 | Spain | T3 | |
| DE69233468T2 | Germany | T2 | |
| EP0971033B1 | European Patent Office (EPO) | B1 | |
| AT447016TThis record | Austria | T | |
| ATE447016T1 | Austria | T1 | |
| DE69233774D1 | Germany | D1 | |
| DK0971033T3 | Denmark | T3 | |
| ES2335720T3 | Spain | T3 | |
| EP0568575B2 | European Patent Office (EPO) | B2 | |
| DK0568575T4 | Denmark | T4 | |
| CA2101774C | Canada | C | |
| ES2236682T5 | Spain | T5 | |
| DE69233468T3 | Germany | T3 |
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Cancelled due to lapse of timeLapsedEELA | EELA | |
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 99109196
Titles2
- German
- PRÜFUNG UND MODELL FÜR ALZHEIMERS-KRANKHEIT
- English
- TEST AND MODEL FOR ALZHEIMERS DISEASE
Classification
- CPC, 15
- C12N15/8509
- A01K67/0278
- A01K2207/15
- A01K2217/00
- A01K2217/05
- A01K2217/072
- A01K2227/105
- A01K2267/0312
- C07K14/4711
- C07K14/575
- C12N2830/008
- C12Q1/6883
- C12Q2600/156
- C12Q2600/172
- A61P25/28
- IPC, 22
- A61K38 00
- C12N15 00
- A01K67 00
- A01K67 027
- A61P25 28
- C07H21 04
- C07K7 06
- C07K14 00
- C07K14 47
- C07K14 575
- C07K16 00
- C12N1 21
- C12N5 10
- C12N15 09
- C12N15 12
- C12N15 85
- C12P21 02
- C12Q1 02
- C12Q1 68
- G01N33 15
- G01N33 50
- G01N33 53